about
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progressionAmyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging.Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography.A European multicentre PET study of fibrillar amyloid in Alzheimer's disease.Positron emission tomography imaging in dementia.Regional neuronal network failure and cognition in late-onset sporadic Alzheimer disease.Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease.Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease.Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET.Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease.Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics.Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients.Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition.Dual-phase [18F]florbetapir in frontotemporal dementia
P50
Q35106472-062B4D68-A704-42B5-BA9C-FDA7C1191DD7Q35905536-85DFE127-4843-4C18-92D1-D2305B9B0284Q36265825-CF5E6A4B-D7A7-4A8F-9D31-15B687FC4DB1Q36434858-BCD38274-9894-4FF9-95BA-B1BC9EFFAF9CQ37150643-8C5F0310-3874-4BA6-BD48-A6389BAF15FBQ38435318-89D3DAD7-8152-4297-BCCC-D0E7DF481615Q38490466-6190B43E-6FC2-48C3-B91C-FDA23FC1870BQ40014398-2B27766A-705B-46C9-832B-3216240AFE5DQ44619067-92DA9D40-3C1A-4904-9F4B-50ECA67EDAA2Q45901591-1D289F8D-0E70-41DC-957D-90F9BC2FD69CQ48345360-75DC3EAA-F085-4FF7-85CE-BC0C7A958CDBQ48346421-2F11031C-B8A0-44C3-A90B-E32FD25F7CE6Q48628621-684AB93E-74CE-4366-A1CE-F1D9065F3EC5Q50706880-521E39C3-4FCF-476B-8793-3CA0A48EADB9Q61443228-8E4C5C21-9390-4322-9308-141BC30B50DE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stephen F Carter
@ast
Stephen F Carter
@en
Stephen F Carter
@es
Stephen F Carter
@nl
type
label
Stephen F Carter
@ast
Stephen F Carter
@en
Stephen F Carter
@es
Stephen F Carter
@nl
prefLabel
Stephen F Carter
@ast
Stephen F Carter
@en
Stephen F Carter
@es
Stephen F Carter
@nl
P108
P106
P21
P31
P496
0000-0002-9080-519X